New strategies to improve clinical outcomes for diabetic kidney disease

New strategies to improve clinical outcomes for diabetic kidney disease

Abstract Background Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to increase, early detection and management of DKD is of...

Full description

Bibliographic Details
Main Authors: Thomas Forst, Chantal Mathieu, Francesco Giorgino, David C. Wheeler, Nikolaos Papanas, Roland E. Schmieder, Atef Halabi, Oliver Schnell, Marina Streckbein, Katherine R. Tuttle
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Medicine
Subjects:
Type 2 diabetes
Diabetic kidney disease
Kidney protective agents
Online Access:https://doi.org/10.1186/s12916-022-02539-2

Internet

https://doi.org/10.1186/s12916-022-02539-2

Similar Items